Drug · DIN 02490366
DACOGEN
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since July 11, 2019.
- Drug Identification Number (DIN)
- 02490366
- Company (DIN owner)
- Otsuka Pharmaceutical Co LtdChiyoda-Ku Tokyo, --, Japan
- Schedule
- Prescription
- Dosage form
- Powder
- Route
- Intravenous
- Therapeutic class (ATC)
- Decitabine L01BC08
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| DECITABINE | 50 MG | VIAL |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 11, 2019: NOC 22390New Drug Submission (NDS)